Friday, June 3, 2011

Medication May Help PTSD Patients Recall Fewer Negative Memories

Petr Malyshev/Shutterstock
A study posted online May 18 in the Journal of Clinical Endocrinology and Metabolism suggests that blocking cortisol could be an effective treatment for posttraumatic stress disorder. The cortisol was blocked by metyrapone, a drug used in the diagnosis of adrenal insufficiency and occassionaly Cushing's syndrome. Researchers found that four days after administration of metyrapone, subjects had far less recall of negative emotional components of a story shown in a video.

Psychiatric News previously reported on another drug that may be useful for the treatment of PTSD--morphine. Researchers found that administering morphine immediately following injury or during resuscitation or early trauma care led to significantly less risk of PTSD. For more information, see


The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.